ClinicalTrials.gov
public full text
Public Domain
The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting
The goal of this clinical research study is to learn if it is tolerable for patients with NSCLC to receive afatinib before surgery. The safety of this drug will also be studied.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neoadjuvant Immunotherapy in Advanced NSCLC#474755
- Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC#878612
- The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China#442086
- Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment#454024
- Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC#852648
Record · ID 1138558
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive